Verily Raises $1 billion Growth Round

Company profile · Healthcare & Life Sciences · Updated Recent

Verily raised $1B in Growth Round financing led by Silver Lake, with participation from Silver Lake, Temasek. AI health research and life sciences platform. The new capital is framed around Scale AI diagnostic tools and expand precision health programs.

Growth Round$1 billionTotal tracked $1 billionSouth San Francisco, CA

What it does

AI health research and life sciences platform. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

Project Baseline enrolled 10,000 participants; AI retinal screening deployed in 20 countries. Management framed the new capital around Scale AI diagnostic tools and expand precision health programs.

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

Recent · Growth Round · $1 billion · Silver Lake

Products & services

Healthcare & Life Sciences workflow monitoring tied to the funding announcement
Customer-facing product described on the company website
Operational tooling for healthcare & life sciences teams
Data capture and reporting across core business processes
Team expansion support funded by the latest round

Open Verily in the interactive Capvizr dashboard →